BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21934213)

  • 1. Practical value of MIB-1 index in predicting behavior of astrocytomas.
    Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
    Indian J Pathol Microbiol; 2011; 54(3):520-5. PubMed ID: 21934213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
    Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
    Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative index in astrocytic tumours.
    Rathi KR; Radotra BD; Khosla VK
    Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular proliferation in pilocytic and diffuse astrocytomas.
    Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
    J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas.
    Johannessen AL; Torp SH
    Pathol Oncol Res; 2006; 12(3):143-7. PubMed ID: 16998593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors.
    Abd El Atti RM; Abou Gabal HH; Osman WM; Saad AS
    Diagn Pathol; 2013 Jul; 8():126. PubMed ID: 23902708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
    Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
    Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma.
    McKeever PE; Strawderman MS; Yamini B; Mikhail AA; Blaivas M
    J Neuropathol Exp Neurol; 1998 Oct; 57(10):931-6. PubMed ID: 9786243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative activity and prognosis of low-grade astrocytomas.
    Schiffer D; Cavalla P; Chiò A; Richiardi P; Giordana MT
    J Neurooncol; 1997 Aug; 34(1):31-5. PubMed ID: 9210051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of histological features in diffuse astrocytomas WHO grade II.
    Lind-Landström T; Habberstad AH; Sundstrøm S; Torp SH
    Int J Clin Exp Pathol; 2012; 5(2):152-8. PubMed ID: 22400076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparative Study of Histopathology of Astrocytomas with Intraoperative Cytology with Special Reference to MIB-1 Labelling Index.
    Sukheeja D; Singhvi S; Rai NN; Midya M
    J Clin Diagn Res; 2015 Aug; 9(8):EC01-3. PubMed ID: 26435950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
    Kirkegaard LJ; DeRose PB; Yao B; Cohen C
    Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.
    Hsu DW; Louis DN; Efird JT; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1997 Aug; 56(8):857-65. PubMed ID: 9258255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
    Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
    J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.